`
`UNITED STATES DISTRICT COURT
`
`SOUTHERN DISTRICT OF CALIFORNIA
`
`NUV ASIVE, INC., a Delaware
`corporation,
`
`Case No.: 18-CV-347-CAB-MDD
`
`Plaintiff,
`
`VERDICT FORM
`
`V.
`
`ALPHA TEC HOLDINGS, INC., a
`Delaware corporation, and
`ALPHA TEC SPINE, INC., a
`California corporation,
`
`Defendants.
`
`Answer each of the following Questions 1 through 6 following the jury instructions
`
`and the instructions given on this Verdict Form.
`
`• "The '832 patent" refers to U.S. Patent No. 8,439,832.
`
`• "The '801 patent" refers to U.S. Patent No. 7,819,801.
`
`• "The '531 patent" refers to U.S. Patent No. 9,974,531.
`
`We, the jury in the above-entitled action, find the following verdict on the
`
`questions submitted to us:
`
`1
`
`
`
`Case 3:18-cv-00347-CAB-MDD Document 402 Filed 03/11/22 PageID.34936 Page 2 of 8
`
`QUESTION 1 - INFRINGEMENT
`
`Did NuVasive prove by a preponderance of the evidence that Alphatec infringed the
`
`following claims of the '801 and '531 patents?
`
`Checking "Yes" below is finding for NuVasive on the issue; checking "No" below
`
`is finding for Alphatec on the issue.
`
`'801 Patent
`
`(For NuVasive)
`
`(For Alphatec)
`
`Claim 1
`
`Claim 2
`
`Claim 15
`
`Claim 16
`
`Claim 26
`
`Yes
`
`Yes
`
`Yes
`
`Yes
`
`Yes
`
`J
`
`J
`
`"
`
`✓
`
`J
`
`No
`
`No
`
`No
`
`No
`
`No
`
`'531 Patent
`
`(For NuVasive)
`
`(For Alphatec)
`
`Claim 1
`
`Claim 39
`
`Yes V - - -
`✓
`- - -
`
`Yes
`
`No
`
`No
`
`Continue to Question 2.
`
`2
`
`
`
`Case 3:18-cv-00347-CAB-MDD Document 402 Filed 03/11/22 PageID.34937 Page 3 of 8
`
`QUESTION 2 - WILLFUL INFRINGEMENT
`
`Did Nu Vasive prove by a preponderance of the evidence that Alphatec willfully
`
`infringed the '832, '801, or '531 patents?
`
`Checking "Yes" below is finding for NuVasive on the issue; checking "No" below
`
`is finding for Alphatec on the issue.
`
`(For NuVasive)
`
`(For Alphatec)
`
`'832 Patent
`
`Yes J
`
`'801 Patent
`
`Yes
`
`'531 Patent
`
`Yes J
`
`j
`
`No
`
`No
`
`No
`
`3
`
`
`
`Case 3:18-cv-00347-CAB-MDD Document 402 Filed 03/11/22 PageID.34938 Page 4 of 8
`
`QUESTION 3 - INVALIDITY
`
`Did Alphatec prove by clear and convincing evidence that any of the claims of the
`
`'832, '801, or '531 patents are invalid as obvious?
`
`Checking "Yes" below is finding for Alphatec on the issue; checking "No" below is
`
`finding for Nu V asive on the issue.
`
`'832 Patent
`
`(For Alphatec)
`
`Claim 1
`
`Claim 3
`
`Claim 9
`
`Yes
`
`Yes
`
`Yes J
`
`Claim 10
`
`Yes
`
`'801 Patent
`
`(For Alphatec)
`
`Claim 1
`
`Claim 2
`
`Claim 15
`
`Claim 16
`
`Claim 26
`
`Yes
`
`Yes J
`Yes ✓
`YesJ
`
`Yes
`
`4
`
`(ForNuVasive)
`
`No
`
`j
`No J
`
`No
`
`No J
`
`(ForNuVasive)
`
`No J
`
`No
`
`No
`
`No
`
`No_J_
`
`
`
`Case 3:18-cv-00347-CAB-MDD Document 402 Filed 03/11/22 PageID.34939 Page 5 of 8
`
`'531 Patent
`
`Claim 1
`
`Claim 39
`
`(For Alphatec)
`
`:::r
`
`(For NuVasive)
`
`No J
`
`No
`
`For the '832 Patent, if you answered "No" for Question 3 (Invalidity) for any claim,
`
`then proceed to answer Questions 4-7.
`
`For the '801 or '531 Patents, if you answered "Yes" for Question 1 (Infringement)
`
`for any claim, and answered "No" for Question 3 (Invalidity) for the same claim,
`
`then proceed to answer Questions 4-7.
`
`Otherwise, do not answer the remaining questions and proceed to check and sign the
`
`Verdict Form at the end of this form.
`
`5
`
`
`
`Case 3:18-cv-00347-CAB-MDD Document 402 Filed 03/11/22 PageID.34940 Page 6 of 8
`
`DAMAGES
`
`QUESTION 4: Has NuVasive shown by a preponderance of the evidence that it is
`
`entitled to lost profits damages for any of Alphatec's sales through September 16,
`
`2020?
`
`Checking "Yes" below is finding for Nu Vasive on the issue; checking "No" below
`
`is finding for Alphatec on the issue.
`
`(ForNuVasive)
`
`Yes J - - - -
`
`(For Alphatec)
`
`No - - - -
`
`Lost Profits
`
`QUESTIONS:
`
`For any sales through September 16, 2020 for which you found that Nu Vasive was
`
`entitled to lost profits, what amount oflost profits damages has NuVasive proven by
`
`a preponderance of the evidence?
`
`6
`
`
`
`Case 3:18-cv-00347-CAB-MDD Document 402 Filed 03/11/22 PageID.34941 Page 7 of 8
`
`QUESTION 6:
`
`For any sales through September 16, 2020 for which you found that NuVasive is not
`
`entitled to lost profits damages, what amount of reasonable royalty damages has
`
`NuVasive proven by a preponderance of the evidence?
`
`$ _q_l_t,_4~\~4~. t)~O_
`
`7
`
`
`
`Case 3:18-cv-00347-CAB-MDD Document 402 Filed 03/11/22 PageID.34942 Page 8 of 8
`
`You have now reached the end of the Verdict Form and should review it to ensure
`
`it accurately reflects your unanimous determinations. The Presiding Juror should
`
`then sign and date the Verdict Form in the spaces below and notify the clerk that
`
`you have reached a verdict.
`
`Please have the Presiding Juror date and sign this form.
`
`Dated: ~ / \\ / 7/l
`
`Presiding Juror
`
`8
`
`